Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBRs cholesterol-decreasing efficacy in patients
doi:10.1172/JCI105893
GLP-1 receptor agonist trials show that participants reach steady-state medication levels and measurable weight reduction (35% body weight loss) by weeks 812
Description Product Information Product Name: Retatrutide (LY3437943), 99.70% purity peptide (TFA removed) Description: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G) , the EC50 values are 5.79 nM, 0.0643 nM, and 0.775 nM respectively [1]
Ozgur E et al
Recommended for: patients who report fatigue during caloric deficit, athletes and active adults, patients optimizing body composition alongside weight loss
US$ 20.32
US$ 23.81
US$ 29.93
US$ 26.06
